|
CN104086401A
|
|
Eicosapentaenoic acid liquid-phase separation purification process system
|
|
CN103965160A
|
|
Synthesis method of hydrogen sulfate clopidogrel intermediate derivative
|
|
CN103772491A
|
|
Nuclear factor-KB polypeptide inhibitor 3 and application thereof
|
|
CN103819540A
|
|
Nuclear factor-KB polypeptide inhibitor and application thereof
|
|
CN103772492A
|
|
Nuclear factor-KB polypeptide inhibitor 4 and application thereof
|
|
CN103772488A
|
|
Polypeptide inhibitor modified with polyethylene glycol for inhibiting vascular endothelial growth factor receptors 2 tyrosine kinase and application thereof.
|
|
CN103772489A
|
|
Nuclear factor-KB polypeptide inhibitor 5 and application thereof
|
|
CN103923179A
|
|
Focal adhesion kinase inhibitor polypeptide and its application
|
|
CN103923188A
|
|
Application of immunoglobulin kappa light chain gene enhancer profilin polypeptides in acute inflammation treatment drugs
|
|
CN103923173A
|
|
Polyethylene glycol modified tubulin polymerization agent polypeptide and its application
|
|
CN103923181A
|
|
Application of immunoglobulin kappa light chain gene enhancer profilin polypeptides in acute inflammation treatment drugs
|
|
CN103923172A
|
|
Application of immunoglobulin kappa light chain gene enhancer profilin polypeptides in acute inflammation treatment drugs
|
|
CN103923170A
|
|
Polyethylene glycol modified tubulin depolymerization agent polypeptide and its application
|
|
CN103923184A
|
|
Focal adhesion kinase inhibitor polypeptide and its application
|
|
CN103923187A
|
|
Focal adhesion kinase inhibitor polypeptide and its application
|
|
CN103923180A
|
|
Interleukin-6 polypeptide inhibitor and its application
|
|
CN103923171A
|
|
Polyethylene glycol modified matrix metalloprotease-2 inhibitor and its application
|
|
CN103923185A
|
|
Interleukin-6 polypeptide inhibitor and its application
|
|
CN103923183A
|
|
Interleukin-6 polypeptide inhibitor and its application
|
|
CN103923182A
|
|
Interleukin-6 polypeptide inhibitor and its application
|
